August 29, 2016 11:57 PM ET

Healthcare Equipment and Supplies

Company Overview of Imricor Medical Systems, Inc.

Company Overview

Imricor Medical Systems, Inc. specializes in developing devices and systems that are compatible with magnetic resonance imaging (MRI). It offers MR-enabled interventional and cardiac ablation products to provide doctors the ability to perform interventional procedures while taking advantage of the soft tissue imaging capabilities of MRI; Vision-MR Ablation Catheter and Advantage-MR EP Recorder/Stimulator System; and interventional devices and systems, implanted device technology licensing, and foundational technology. The company was founded in 2006 and is based in Burnsville, Minnesota.

400 Gateway Boulevard

Burnsville, MN 55337

United States

Founded in 2006





Key Executives for Imricor Medical Systems, Inc.

Chairman of The Board, Chief Executive Officer and President
Chief Financial Officer
Vice President of Operations
Vice President of Engineering
Vice President of Research
Compensation as of Fiscal Year 2016.

Imricor Medical Systems, Inc. Key Developments

Imricor Announces Enrollment of First Patients in Clinical Study to Evaluate Vision-MR Ablation Catheter for Real-Time MR-Guided Ablation Procedures

Imricor Medical Systems announced the enrollment of the first patients in a clinical study to evaluate the Vision-MR Ablation Catheter for the treatment of atrial flutter under real-time MRI guidance. The study is sponsored by the Leipzig Heart Center in Leipzig, Germany. Professor Gerhard Hindricks MD, Head of the Department of Electrophysiology at the heart center, is the principal investigator. This single-center study will enroll up to 35 patients. Imricor's Vision-MR catheter, when used with the Advantage-MR EP Recorder/Stimulator System, allows physicians to perform cardiac ablations under MRI guidance. With real-time MRI, physicians can individualize the ablation for each patient's unique cardiac structure and substrate. In addition, they can assess lesion quality and fill gaps in ablation lines during the initial procedure. Ablations guided by MRI have the potential to improve outcomes and provide safer, more cost-effective treatment - all in an environment that is free of radiation for both the patient and physician.

Imricor Medical Systems, Inc. Announces License Agreement with Sorin Group

Imricor Medical Systems, Inc. announced that it has entered into a license agreement with Sorin Group to develop magnetic resonance imaging (MRI) compatible leads for use with Sorin implantable cardiac rhythm management devices.

Similar Private Companies By Industry

Company Name Region
.decimal, Inc. United States
20/20 GeneSystems, Inc. United States
20/20 Imaging LLC United States
21st Century Scientific, Inc. United States
21X Corporation United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Imricor Medical Systems, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at